Donald P. Reitberg

1.3k total citations
26 papers, 1.1k citations indexed

About

Donald P. Reitberg is a scholar working on Pharmacology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Donald P. Reitberg has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Donald P. Reitberg's work include Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Donald P. Reitberg is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (11 papers), Antibiotic Resistance in Bacteria (3 papers) and Drug Transport and Resistance Mechanisms (2 papers). Donald P. Reitberg collaborates with scholars based in United States, France and Russia. Donald P. Reitberg's co-authors include Jerome J. Schentag, Thomas J. Cumbo, W. S. Singleton, Menger Chung, Michael Gaffney, Lawrence S. Blaszkowsky, Jeffrey A. Meyerhardt, Alona Muzikansky, Pankaj Bhargava and Kerry Horgan and has published in prestigious journals such as Annals of Internal Medicine, Cancer and Annals of Surgery.

In The Last Decade

Donald P. Reitberg

26 papers receiving 984 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald P. Reitberg United States 13 233 204 164 162 143 26 1.1k
M Biour France 18 209 0.9× 153 0.8× 261 1.6× 178 1.1× 164 1.1× 80 1.4k
Andrew K. Trull United Kingdom 23 117 0.5× 240 1.2× 323 2.0× 111 0.7× 227 1.6× 53 1.4k
William A. Briggs United States 23 118 0.5× 210 1.0× 157 1.0× 101 0.6× 77 0.5× 55 1.6k
Yousri M. Barri United States 21 89 0.4× 324 1.6× 190 1.2× 277 1.7× 253 1.8× 35 1.8k
Manuel Díaz‐Rubio Spain 33 136 0.6× 369 1.8× 496 3.0× 214 1.3× 164 1.1× 85 2.2k
Raymond G. Morris Australia 24 325 1.4× 230 1.1× 110 0.7× 285 1.8× 39 0.3× 92 1.8k
Chantal Le Guellec France 21 223 1.0× 213 1.0× 156 1.0× 286 1.8× 43 0.3× 59 1.3k
D S Rampton United Kingdom 20 411 1.8× 218 1.1× 388 2.4× 100 0.6× 40 0.3× 49 1.7k
R P Walt United Kingdom 26 258 1.1× 186 0.9× 235 1.4× 144 0.9× 109 0.8× 65 2.3k
Guy Aymard France 18 164 0.7× 139 0.7× 256 1.6× 81 0.5× 67 0.5× 35 1.5k

Countries citing papers authored by Donald P. Reitberg

Since Specialization
Citations

This map shows the geographic impact of Donald P. Reitberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald P. Reitberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald P. Reitberg more than expected).

Fields of papers citing papers by Donald P. Reitberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald P. Reitberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald P. Reitberg. The network helps show where Donald P. Reitberg may publish in the future.

Co-authorship network of co-authors of Donald P. Reitberg

This figure shows the co-authorship network connecting the top 25 collaborators of Donald P. Reitberg. A scholar is included among the top collaborators of Donald P. Reitberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald P. Reitberg. Donald P. Reitberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Thompson, Gary A., et al.. (2015). Guaifenesin Pharmacokinetics Following Single‐Dose Oral Administration in Children Aged 2 to 17 Years. The Journal of Clinical Pharmacology. 56(7). 894–901. 6 indexed citations
3.
4.
Christopher, Lisa J., Donghui Cui, Chi‐Yuan Wu, et al.. (2008). Metabolism and Disposition of Dasatinib after Oral Administration to Humans. Drug Metabolism and Disposition. 36(7). 1357–1364. 158 indexed citations
5.
Zhu, Andrew X., Keith Stuart, Lawrence S. Blaszkowsky, et al.. (2007). Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma. Cancer. 110(3). 581–589. 190 indexed citations
6.
Reitberg, Donald P., et al.. (2005). Advances in Single-Patient Trials for Drug Treatment Optimization and Risk Management. Drug Information Journal. 39(2). 119–124. 1 indexed citations
7.
Meltzer, Eli O., Thomas B. Casale, Morris S. Gold, et al.. (2003). Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study. Annals of Allergy Asthma & Immunology. 90(1). 79–86. 7 indexed citations
8.
Fant, Reginald V., Jack E. Henningfield, Saul Shiffman, Kenneth R. Strahs, & Donald P. Reitberg. (2000). A pharmacokinetic crossover study to compare the absorption characteristics of three transdermal nicotine patches. Pharmacology Biochemistry and Behavior. 67(3). 479–482. 70 indexed citations
9.
Sanders, Steven W., Keith G. Tolman, & Donald P. Reitberg. (1992). Effect of a single dose of lactase on symptoms and expired hydrogen after lactose challenge in lactose-intolerant subjects.. PubMed. 11(6). 533–8. 20 indexed citations
10.
11.
Bachmann, K, et al.. (1988). Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients. Antimicrobial Agents and Chemotherapy. 32(5). 730–735. 21 indexed citations
12.
Johnson, Curtis A., et al.. (1988). Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis. Antimicrobial Agents and Chemotherapy. 32(1). 51–56. 12 indexed citations
13.
Chung, Menger, Donald P. Reitberg, Michael Gaffney, & W. S. Singleton. (1987). Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. The American Journal of Medicine. 83(6). 10–14. 119 indexed citations
14.
Reitberg, Donald P., et al.. (1985). A Rapid, Universal TI-59 Model-Independent Pharmacokinetic Analysis Program based on Statistical Moment Theory. Drug Intelligence & Clinical Pharmacy. 19(2). 125–134. 2 indexed citations
15.
Reitberg, Donald P., Thomas J. Cumbo, A. Ian Smith, & Jerome J. Schentag. (1984). Effect of protein binding on cefmenoxime steady-state kinetics in critical patients. Clinical Pharmacology & Therapeutics. 35(1). 64–73. 17 indexed citations
16.
Schentag, Jerome J., Donald P. Reitberg, & Thomas J. Cumbo. (1984). Cefmenoxime Efficacy, Safety, and Pharmacokinetics in Critical Care Patients with Nosocomial Pneumonia. The American Journal of Medicine. 77(6). 34–42. 130 indexed citations
17.
Reitberg, Donald P. & J J Schentag. (1983). Liquid-chromatographic assay of cefmenoxime in serum and urine.. Clinical Chemistry. 29(7). 1415–1418. 8 indexed citations
18.
Swanson, Douglas J., Donald P. Reitberg, A. Ian Smith, Philip B. Wels, & Jerome J. Schentag. (1983). Steady-state moxalactam pharmacokinetics in patients: Noncompartmental versus two-compartmental analysis. Journal of Pharmacokinetics and Biopharmaceutics. 11(4). 337–353. 8 indexed citations
19.
Reitberg, Donald P., et al.. (1982). Evaluation of two concurrent drug-delivery systems in a skilled-nursing facility. American Journal of Health-System Pharmacy. 39(8). 1316–1320. 3 indexed citations
20.
Reitberg, Donald P., et al.. (1981). Alteration of Theophylline Clearance and Half-life by Cimetidine in Normal Volunteers. Annals of Internal Medicine. 95(5). 582–585. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Biour Breakdown of academic impact, for papers by Andrew K. Trull Breakdown of academic impact, for papers by William A. Briggs Breakdown of academic impact, for papers by Yousri M. Barri Breakdown of academic impact, for papers by Manuel Díaz‐Rubio Breakdown of academic impact, for papers by Raymond G. Morris Breakdown of academic impact, for papers by Chantal Le Guellec Breakdown of academic impact, for papers by D S Rampton Breakdown of academic impact, for papers by R P Walt Breakdown of academic impact, for papers by Guy Aymard
Rankless by CCL
2026